• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX22522UX
Device Problems Complete Blockage (1094); Material Deformation (2976)
Patient Problems Chest Pain (1776); Occlusion (1984); ST Segment Elevation (2059)
Event Date 06/11/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A resolute onyx 2.00x30 mm drug eluting stent was intended to be used during a procedure.The intended lesions were in the mid to proximal lad, with severe tortuosity and severe calcification.There was sequential 70 and 80 % stenosis in the lesions.No damage was noted to packaging.No issues when removing the device from the hoop.Device was inspected without issues.It is reported that stent deformation occurred-longitudinal stent deformation caused by a guide liner and an additional stent was attempted to be overlapped proximally.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was encountered when advancing the device.Excessive force was not used during the delivery.A guideliner was used to aid in delivery to the lesion.The device was deployed without issue.When an additional stent was to be put in proximally, the proximal edge of the first stent could not be crossed.There was an attempt with a guideliner to advance the second stent but again, it did not cross.An angiogram was then performed, and it was noted that 4-5mm of one of the stents had crushed upon itself.No damage was noted to the stent that was deployed proximally during advancement/deployment.A stent was deployed proximally and again it was attempted to cross the distal stent.The stent then became occluded and st elevation occurred with chest pain.It was noted that the st elevation resolved after a few minutes.Finally, a small 1.2x8 mm balloon was able to cross, and it opened up the proximal stent edge.Another resolute onyx was placed to bridge the gap between the two stents.No patient injury is reported.
 
Manufacturer Narrative
Patient history: prior pci.Patient hospitalised with chest pain with an acute non-stemi at time of procedure.Additional updated information: the 2.0x30mm resolute onyx was deployed without issue in the mid lad at 12 atm for 30 secs.The stent that was deployed proximally was a resolute onyx stent (2.25x22mm).The 2.25x22mm resolute onyx stent was deployed in the ostial lad in a non-overlapping fashion, as it could not be advanced into the mid-lad.It was deployed at 12 atm for 30 secs.No damage was noted to this stent.An angiogram was then performed, and it was noted that 4-5mm of the proximal stent edge of the 2.0x30mm stent in the mid lad became longitudinally compressed when trying to advance the proximal lad stent.The proximal 5mm of the mid lad stent became compressed more distally at the proximal edge of the mid lad stent.Subsequent to the proximal lad stent deployment, the lad began to have reduced flow (occlusion).The patient began to have some chest pain and transient st segment elevations.Several attempts were made to advance several balloons past the compressed proximal stent edge in the mid lad.A 1.2x8mm non-medtronic balloon was finally advanced across the proximal stent edge and balloon angioplasty was performed with the 1.2x8mm balloon and other balloons.A 2.25x12mm resolute onyx drug eluting stent was then deployed in the mid lad to bridge the gap between the two stents.The entire stented segment was post dilated with non-medtronic balloons and with the balloon of the 2.25x12mm resolute onyx.The placing of the three overlapping stents was successful.The chest pain and st segment elevations were resolved.The st segment elevations lasted less than 10 mins.The procedure was completed.The patient was in stable condition with no further chest pains.There was no residual stenosis post procedure.No further patient complications reported.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Cine image review: the images show the lesion in the lad as reported by the account.Pre dilation of the lad lesion is shown in the images.A stent is delivered and deployed in the mid lad.An attempt is made to deliver a second overlapping stent through the proximal portion of the mid lad stent.The proximal struts of the mid lad stent become compressed as shown by the darker region at the proximal portion of the mid lad stent.A second stent is deployed in the proximal lad.The deformed struts of the mid lad stent are visible in the image.A contrast image is taken and shows reduced flow in the lad vessel at the location of the mid lad stent.A small dilation balloon is passed through the proximal opening of the mid lad stent and retracted repeatedly.An angiogram then shows improved flow in the lad.A third stent is deployed between the mid lad stent and the proximal lad stent.A final angiogram shows the treated lad with improved flow as shown by the flow of contrast through the vessel.There were no images of the proximal lad stent failing to cross the mid lad stent.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7684643
MDR Text Key113867810
Report Number9612164-2018-01712
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 01/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/04/2020
Device Catalogue NumberRONYX22522UX
Device Lot Number0008982441
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2019
Date Device Manufactured02/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient Weight68
-
-